From the Food and Drug Administration.
Nightingale
S L
SL
D001067:Appetite Depressants / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control; D002839:Chromans / Q000009:adverse effects*; D004348:Drug Labeling; D005277:Fenfluramine / Q000009:adverse effects*; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008327:Mammography / Q000592:standards*; D011786:Quality Control; D013844:Thiazoles / Q000009:adverse effects*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States; D014486:United States Food and Drug Administration
D001067:Appetite Depressants; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D005277:Fenfluramine; D000077288:Troglitazone